Dr. Christine Collier has been a clinical biochemist for over 30 years. She is the 2024 recipient of the Canadian Society of Clinical Chemists (CSCC) Outstanding Contribution to Clinical Chemistry, an award presented as a mark of recognition of outstanding achievement in and/or contribution to the field of clinical chemistry. Dr. Collier has an unwavering commitment to the field of clinical biochemistry, with boundless energy and positive leadership, and has been dedicated to advancing clinical biochemistry. She leaves an indelible mark on her peers and the profession.

Dr. Collier’s career has spanned over three decades. Originating from her MSc and PhD studies at the Hospital for Sick Children in Toronto, her interest in clinical chemistry blossomed. Dr. Collier became a Fellow of the Canadian Academy of Clinical Biochemistry in 1989 after completing the Clinical Biochemistry Post-Doctoral Residency Program at the University of Manitoba and a post-doctoral fellowship at the Memorial Sloan Kettering Cancer Centre in New York. From there she practiced as a Clinical Biochemist at Kingston General Hospital (KGH) until 2017, and concurrently led as the Service Chief of Clinical Chemistry from 2008 to 2013. During this time, she also provided consultation services to three additional hospitals. In 2017, she moved to LifeLabs in Ontario and worked there until 2019, after which she joined Fraser Health in British Columbia, where she currently practices and is appointed as a Clinical Professor at the University of British Columbia.

Dr. Collier has made a substantial contribution to teaching and education. She was the architect behind the CSCC/Canadian Academy of Clinical Biochemistry (CACB)’s Maintenance of Competency Program and has significantly influenced the professional development of clinical biochemists across Canada for over two decades. Alongside Dr. Paul Yip, she established the biweekly CSCC Education Roundtables, a pivotal educational platform available across Canada. More locally, Dr. Collier coordinated the clinical chemistry rotation for Queen’s University postgraduate residents from 1992 to 2009 and was site director of the St. Lawrence College MLT Training Program from 1996 to 2005. On a day-to-day basis, she remains an invaluable mentor with a wealth of experience for both laboratory technical staff and junior clinical biochemist colleagues, alongside supporting the broader medical community.

Dr. Collier is a leader in shaping how clinical biochemists practice both nationally and internationally. Her contributions to advancing Canadian clinical biochemistry are exemplified through her authorship on CSCC Guidance, Position Statements, and Recommendations, including co-authoring manuscripts in areas such as POCT quality indicators, harmonized clinical laboratory lipid reporting recommendations, and candidate recommendations for protein electrophoresis reporting. Dr. Collier is also co-chair of the CSCC Working Group on the Harmonization of Reference Intervals (hRI) and has worked on numerous international endeavours (e.g. IATDMCT and CLSI).

Dr. Collier has further aimed to push the envelope when it comes to dedication to quality lab testing. She was involved in Ontario’s Quality Management Program – Laboratory Service (QMP-LS, now Institute for Quality Management in Healthcare), and supported numerous quality initiatives at KGH, such as the MU program, serving as the first Chair of the Decentralized Laboratory Testing Committee (later POCT Committee) and acting as the first Chair of the Pathology Quality Assurance Committee.

Finally, Dr. Collier is highly collaborative and actively seeks to promote and enhance the profession. She has worked extensively with the CSCC in various roles and capacities, such as serving as Registrar of continuing education credits, Chair of the Professional Affairs Committee and of the Professional Development Program Committee, Co-Coordinator of the CSCC Education Roundtables, Co-Chair of the CSCC Working Group on hRI, and Chair of the Archives Committee. With the Ontario Society of Clinical Chemists, she was also the Chair of the Professional Affairs Committee and served as President from 2004-2005. You may have also seen her name pop up now and again on the IATDMCT listserv, the CSCC general listserv, and the OSCC listserv to engage the community. She has published more than 50 papers within clinical biochemistry, and has received several other awards for her contribution to clinical biochemistry.

Dr. Collier has had a remarkable career with tremendous success in education and quality. Thank you for supporting the profession and making it better for future generations.

1. The Award shall be presented as a mark of recognition of outstanding achievement in and/or contribution to the field of clinical chemistry.
2. The Award shall usually be presented annually, but if in the opinion of the Awards Committee no suitable candidate is available in any year, the Award shall not be made.
3. Siemens has agreed to make an annual contribution of $3,000 CDN to sponsor this award. A framed certificate and an honorarium in the amount of $1,500 shall accompany the Award. The balance of $1,500 remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed scroll, and to make a contribution towards expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
4. The Awards Committee shall choose the recipient of the Award.
5. The Awards Committee shall report its choice to the Council of the Society at its Winter Meeting in the year for which the Award is made.
6. The President of the Society will notify the recipient(s) of the award and inform Siemens Inc. of the name of the recipient(s) of the Award not later than March 1, in the year for which the Award is made.   7. The recipient of the Award is not usually expected to give an address or give a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society.  A representative of Siemens shall be invited to participate in the presentation.
7. No formal nomination procedure is specified, but members of the Society may propose suitable candidates to the Awards Committee through the Head Office of the Society.  Curriculum vitae and other suitable documentation in support of the nominee must accompany nominations from the membership.  Proposals shall be solicited annually in the Newsletter of the Society.
8. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the sponsor of the Award.  Council of the Society and the corporate sponsor of this award should review these terms of reference a minimum of once every 5 years.

The CSCC Award for Innovation in Laboratory Medicine is presented to a clinical laboratory in Canada that has distinguished itself by outstanding accomplishment through innovation in the field of clinical chemistry, pathology, or laboratory medicine. The 2024 recipient is Laboratory Medicine and Molecular Diagnostics – Division of Clinical Chemistry at Sunnybrook Health Sciences Centre.

The Sunnybrook team supported work that led to Sunnybrook becoming the first hospital in North America to use two new assays in clinical care to diagnose preeclampsia (PE) in a pregnancy. Clinicians at this hospital now have the latest tools to diagnose PE more accurately and support the hospital’s ongoing efforts to bring precision medicine and individualized care to patients. The work began in 2019 and included a multidisciplinary team of specialists from several departments (Obstetrics and Gynecology, Nephrology, Laboratory Medicine) to introduce two new assays: soluble fms-like tyrosine kinase 1 (sFLT-1) and placental growth factor (PlGF). Analytical validation included collaboration with the Oxford University Hospitals, as they led the first real world evaluation of these markers to support the current standard of clinical practice in the UK. Sunnybrook also established a well characterized sample bank, including patient diagnoses, that has aided other Canadian labs to establish their local service. This work has enabled Sunnybrook to determine individualized risk of PE for women that are pregnant presenting with elevated blood pressure, based on the sFlt/PlGF ration results. Importantly they showed that this ratio had higher diagnostic accuracy over PlGF alone and with traditional testing for proteinuria.

The project aimed to address three key goals, all of which were met.

• Goal 1: Reduce rate of unnecessary admission to the high-risk obstetrical unit for suspected PE.
• Goal 2: Avoid unnecessary follow-up visits at the outpatient clinical and obstetrical day unit.
• Goal 3: Decrease the risk of missing or delaying the diagnosis of severe PE in women with atypical presentation, and thereby decrease the risk of associated maternal morbidity.

Insight from this information is being shared to colleagues to improve diagnosis and treatment of PE, to reduce morbidity for women and babies, and to improve healthcare system sustainability. Information from this work has been shared at medical grand rounds, professional conferences, and has been included in two published research articles and an invited book chapter. The banked samples have been freely shared with several institutions across Canada, and the Sunnybrook Foundation has also shared the positive impact of this project with the public. In the information sharing with the public, the direct contribution of the clinical biochemistry lab to patient care was showcased. The value in being able to avoid unnecessary interventions, alongside helping to find very sick patients, is highly value-add to the health system. This team has truly showed the importance of clinical biochemistry within maternal patient care, and have done so through professional leadership, academic scholarship, and exemplary service.

The leadership team for this work includes:

• Lei Fu
• Liyan Ma
• Paul Yip

Additional collaboration was provided by:

• Nir Melamed
• Jon Barrett
• Arthur Zaltz
• Nanette Okun
• Michelle Hladunewich

1. The Award shall be presented to a Clinical Laboratory in Canada that has distinguished itself by outstanding accomplishment through innovation in the field of Clinical Chemistry, or Pathology and Laboratory Medicine for projects where a CSCC member was directly involved. This award is intended to encourage and recognize excellence in Clinical Laboratory Services especially in the role of improving the quality of health care, improving patient outcomes, and promoting a positive public image to clinical laboratories and laboratory professionals.
2. Eligible organizations for this award include:
   1. Private, Academic and Government Clinical Laboratories and Laboratory divisions.
   2. Rural and Regional Clinical Laboratories and Clinical Laboratory Departments.
3. Laboratories demonstrating outstanding accomplishments in one or more of the following areas completed within the last two calendar years are eligible for consideration:
   1. Innovation in strategic planning and implementation of laboratory services based on best practices.
   2. Innovation in development of new laboratory programs (e.g. new tests, facilities, and changes in practice).
   3. Innovation in teaching and education. 3.4. Promotion of a positive public image for laboratory medicine.
4. Nominations for this award will be received from members of the CSCC to the Awards Committee through the Head Office of the Society. Nominations for this award will include:
   1. A summary of the accomplishment(s) of the nominated organization with supporting documentation.
   2. A letter of support from a CSCC member involved in the project for which the organization is being nominated.
   3. A letter of support from the nominee’s organization administrative team (Signed by a Department Director, VP, or CEO).
5. Nominees having received this award within the last 3 years will not be eligible to receive this award for a current year.
6. Nominations for this award shall be solicited annually in the Newsletter of the Society.
7. The Award shall usually be presented annually, but if in the opinion of the Awards Committee there is no suitable candidate(s) available in any year, the Award shall not be made.
8. The CSCC supporting member and a representative from the administration of hospital or institution represented in the project will be invited to accept the award (plaque and display item) at the CSCC Annual Meeting banquet. The award will be presented by a representative from Roche Diagnostics. The award will cover airfare, accommodations and expenses for 2 nights for both recipients, as per the CSCC Travel Guidelines. Photographs and a brief summary of the award will be provided to the hospital or institution for their publication.
9. The Awards Committee shall select one of the nominees for the Award for recommendation to Council of the Society.
10. The Awards Committee shall report its recommendation to the Council of the Society for approval at its Winter Council meeting in the year for which the Award is to be made.
11. The President of the Society will notify the recipient organization of the Award, and inform Roche Diagnostics of the name of the recipient of the award, not later than March 1 in the year in which the Award is made.
12. The recipient of the Award is not usually expected to give an address, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society.
13. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the donor of the Award and should be reviewed at least every five years.

https://cscc-sccc.ca/wp-content/uploads/Awards/InnovationAward/Application_Form_CSCC_Laboratory_Innovation_Award.pdf

Dr. Andrew Lyon is the recipient of the 2024 CSCC Award for Research Excellence. This award is presented to an individual or group as a mark of recognition of their contribution to research directly or indirectly related to clinical chemistry in Canada.

Dr. Lyon has provided significant research contributions to the field of clinical biochemistry during his career of over 30 years. This is particularly remarkable as they have occurred alongside his notable teaching endeavors and numerous demanding clinical service positions. Dr. Lyon’s publication history demonstrates a long career of research in a wide number of areas, from general clinical biochemistry and maternal/child health to data mining/analysis.  This demonstrates his comprehensive knowledge, understanding, and experience in many areas of laboratory medicine. He has published 101 peer reviewed articles, 19 non peer reviewed articles, 7 book chapters, and 128 abstracts/proceedings/letters. The wide array of areas of publication demonstrates his breadth of interests and includes: electrolytes, glucose, bilirubin, occult blood, newborn screening, urinalysis, HbA1c, bone markers, ethanol, toxicology, prenatal screening, pregnancy, POCT, hematology, allergy, pediatric chemistry, diabetes, renal disease, thyroid, troponin, amyloidosis, genetics, biomonitoring, test utilization, reference intervals, metals, telehealth, pandemic, veterinary medicine, and more.

Although Dr. Lyon has his own research passions, he has most often participated collaboratively on teams to accomplish the work. The teams often include other clinical biochemists, clinicians, and fellows/students. This has enabled Dr. Lyon to be a mentor to other researchers, and to foster relationships beyond the clinical laboratory, supporting and positively enhancing the clinical biochemistry and laboratory medicine profile.

In addition to leading and participating in research projects, Dr. Lyon has also served on local and regional research committees, helping to identify worthy research activities, and promoting high standards of research. This lends to his personal and collegial manner, as he demonstrates that he is willing to support others that have laboratory questions or would like to further investigate a problem. He is keen to offer his knowledgeable and helpful advice, which further opens collaborative research projects and publications. This has also led to opportunities for supporting journal and grant reviews, knowledge sharing at local, national and international conferences and meetings, alongside being able to collaboratively obtain research funding.

1. The Award shall be presented to an individual or group, as a mark of recognition of their contribution to research directly or indirectly related to clinical chemistry in Canada.
2. The Award shall usually be presented annually, but if in the opinion of the Awards Committee no group or individual is available in any year, the Award shall not be made.
3. Ortho-Clinical Diagnostics have agreed to make an annual contribution of $3,000 CDN. The Award shall be accompanied by a framed certificate and by an honorarium in the amount of $1,500. The balance of $1,500 remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed scroll, and to make a contribution towards expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
4. The Awards Committee shall choose the recipient(s) of the Award.
5. The Awards Committee shall report its choice to the Council of the Society at its Winter Meeting for the year for which the Award is made.
6. The President of the Society will notify the recipient(s) of the award and inform Ortho Clinical Diagnostics of the name of the recipient(s) of the Award not later than March 1, in the year for which the Award is made. . 7. The recipient(s) of the Award is (are) not usually expected to give an address or present a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society.  A representative of Ortho-Clinical Diagnostics shall be invited to participate in the presentation.
7. No formal nomination procedure is specified, but members of the Society may propose suitable candidates to the Awards Committee through the Head Office of the Society.  Curriculum vitae and other suitable documentation in support of the nominee must accompany nominations from the membership.  Proposals shall be solicited annually in the Newsletter of the Society.
8. The amendment of these Terms of Reference is the responsibility of the Council of the Society, subject to the concurrence of the sponsor of the Award.  Council of the Society and the corporate sponsor of the Award should review these Terms of Reference a minimum of once every five years.

Dr. Laurel Thorlacius is the recipient of the 2024 CSCC Award for Education Excellence. This award is presented to an individual or group as a mark of recognition of outstanding contribution to education in the field of clinical chemistry. Dr. Thorlacius is a Medical Director at Shared Health Manitoba and Associate Professor in the Department of Pathology and in the Department of Biochemistry and Medical Genetics at the Rady Faculty of Health Sciences, University of Manitoba. Dr. Thorlacius is also a Fellow of the Canadian Academy of Clinical Biochemistry, and member of CSCC Quality Indicators and Point of Care special interest groups.

Dr. Thorlacius has been a mentor in education, both in formal and informal settings, as she is an inspiring and dedicated colleague and teacher. Dr. Thorlacius joined Shared Health in 2006, and since then she has trained six Clinical Biochemistry Post-Doctoral trainees. She is an engaged teacher who encourages trainees to think critically, to evaluate and to have open discussions. She dedicates numerous formal and informal teaching hours to trainees in areas such as pre-analytical topics, automated chemistry testing and quality in laboratory medicine. She is known to always keep her door open, supporting trainees to reach out regardless of their current area of rotation. She truly leads by example, creating a positive environment and endless opportunities to learn and collaborate.

Numerous clinical biochemists have had Dr. Thorlacius as a mentor, including those who continue to work with her at Shared Health and others who have moved to new opportunities across North America. She is always welcoming and willing to teach and share her extensive knowledge and experience as a clinical biochemist, whether you are across the hall or across the country. In addition, she formally serves on the committee for the University of Manitoba Clinical Biochemistry Post-Doctoral training program, dedicating her time to the review of applications, trainee selection, curriculum updates and leading monthly trainee academic sessions. She was also the co-chair of the CSCC 2020 and the 2023 Annual Meeting that were held jointly with the Canadian College of Medical Geneticists.

Dr. Thorlacius’ commitment to education extends far beyond training young clinical biochemists. She has contributed to teaching various courses at the University of Manitoba, sharing her knowledge and passion for laboratory medicine with undergraduate and graduate students. She has been actively engaged with medical students and residents, medical laboratory technologists and lab assistants, supervisors, and managers.

Her passion for education extends to ensuring her knowledge is shared in publications, at conferences, and through other collaborative opportunities with colleagues. For example, within her team participation on the Kidney Check project, she was awarded the 2022 UNIVANTS Healthcare Excellence Award for Kidney Check, The Next Generation Surveillance for Hypertension, Diabetes and Chronic Kidney Disease, winning best in North America and one of three for Top Global. In 2021, she received the CSCC Award for Innovation in Laboratory Medicine for Kidney Check project. She has always been actively engaged with clinicians in Manitoba on implementation of Choosing Wisely, test utilization and provincial standardization initiatives.

The Award shall be presented to an individual or group as a mark of recognition of outstanding contribution to education in the field of clinical chemistry.

2. The Award shall usually be presented annually, but if in the opinion of the Awards Committee no suitable candidate is available in any year, the Award shall not be made.
3. Beckman Coulter Canada Inc. have committed to an annual contribution of $3,000 CDN. A framed certificate and an honorarium in the amount of $1,500 shall accompany the Award.  The balance of $1,500 remaining after the honorarium shall be used to meet the administrative expenses, the production of the framed scroll and to make a contribution towards the expenses involved in ensuring the attendance of the recipient at the Annual Conference of the Society.
4. The Awards Committee shall choose the recipient(s) of the Award.
5. The Awards Committee shall report its choice to the Council of the Society at its Winter Meeting in the year for which the Award is made.
6. The President of the Society will notify the recipient(s) of the award and inform Beckman Coulter Canada Inc. of the name of the recipient(s) of the Award not later than March 1, in the year for which the Award is made.
7. The recipient(s) of the Award is (are) not usually expected to give an address or present a paper, but the Award and the reading of the citation shall usually be made at the Annual Conference of the Society.  Representatives of Beckman Coulter Canada Inc. shall be invited to participate in the presentation.
8. No formal nomination procedure is specified, but members of the Society may propose suitable candidates to the Awards Committee through the Head Office of the Society. Curriculum vitae and other suitable documentation in support of the nominee must accompany nominations from the membership. Proposals shall be solicited annually in the Newsletter of the Society.
9. The amendment of these Terms of Reference is the responsibility of the Council, subject to the concurrence of the sponsor of the Award.  The CSCC Council and the corporate sponsor of the Award should review these Terms of Reference a minimum of once every five years.

ELIGIBILITY REQUIREMENTS
1. Applicants must be members of the CSCC.
2. Applicants must be enrolled EITHER in a CACB-accredited clinical biochemistry training program OR
in a Royal College of Physicians and Surgeons of Canada-accredited medical biochemistry training
program.

ADDITIONAL REQUIREMENTS
1. The Host Laboratory must perform clinical service in biochemistry, hematology, microbiology,
immunology, genetics, and/or a related area.
2. The Host Laboratory must be located outside of the home city of the Applicant’s training program.
3. Funds must be used within one year of being awarded or before completion of the training program,
whichever is earlier.
4. Successful Applicants must submit a summary article of their visit to CSCC News before completion
of their training program. The article should describe goals that were achieved during the visit and
how Applicants plan to apply their new knowledge in the future. Applicants should coordinate the
length and timing of their articles with the Editor in Chief of the publication.

APPLICATION PROCESS
An application form is included with this Terms of Reference. Applicants are to send their completed
application form, together with all other required materials, to CSCC Head Office (office@cscc.ca).
Applications are accepted on an on-going basis throughout the year.

AWARDING OF GRANTS
CSCC Head Office will forward all applications to the Head of CSCC Education & Scientific Affairs Division
who will then appoint up to three (3) reviewers per application. All reviewers are required to be CSCC
members; one should be the Head of Professional Affairs and one should be a CSCC Councillor if there is
no conflict of interest. In awarding the grants, preference will be given to Applicants who will be in their
final year of study during the proposed visit and/or have not previously received a CSCC Trainee Elective
Visit Grant. Whenever possible, grants will be distributed across two or more training programs each
year. Head Office will notify Applicants of the reviewer panel’s decision within one (1) month of
receiving applications.

Updated and approved by CSCC Council on June 2, 2018.

Terms of Reference and Application Form

Download PDF

Terms of Reference

1. The Grant shall be presented to a member of the CSCC to support leadership and/or administrative contributions in the field of Clinical Chemistry or Pathology and Laboratory Medicine. This award is intended to encourage and support the administrative and leadership role of Laboratory Physicians and Scientists including (but not limited to):
a) administrative positions in hospitals, universities, private laboratories, government and
industry,
b) participation in committees of Provincial, National and International professional and
regulatory agencies,
c) leadership role in the strategic planning and implementation of laboratory services.

2. The Grant shall usually be presented annually, but if in the opinion of the Awards Committee no suitable candidate(s) is available in any year, the Grant shall not be made. The deadline for application for the grant shall be November 30 of the previous year.

3. Recipients of the Grant shall receive a maximum of $3,000. The grant is to be distributed to as many applicants as is appropriate. This honorarium is to be used to support and facilitate the administrative/leadership activities of the recipient (e.g. travel expenses associated with participating on national/international committees (e.g. IFCC, WHO, NIH, etc.), presentations at conferences, educational courses in administration and management.

4. The Awards Committee shall choose the recipient of the Award.

5. The Awards Committee shall report its choice to the Council of the Society not later than January 15 in the year for which the Grant is made.

6. The President of the Society will notify the recipient(s) of the Grant not later than March 1 in the year in which the Grant is made.

7. The recipient of the Grant is not usually expected to give an address or present a paper, but the Grant and the reading of the citation shall usually be made at the Annual Conference of the Society.

8. Candidates will submit an application to the Awards Committee through the Head office of the Society. Proposals shall be solicited annually in the Newsletter of the Society.

9. The amendment of these Terms of Reference is the responsibility of the Council and should be reviewed at least every five years.

CSCC Grant for Leadership Application Form

Download Trainee Grant TOR

Participation in the Annual Conference of the CSCC provides trainees in laboratory medicine with a valuable opportunity to increase their knowledge in laboratory medicine and related fields, to discuss their work with colleagues, and to establish novel collaborative relationships.

CSCC is providing a limited number of Trainee Travel Grants each year in support of this important facet of laboratory medicine training. Trainees are encouraged to apply for these grants if they meet all the following criteria:

1. They are members of the CSCC.
2. They are enrolled EITHER in a CACB-accredited clinical biochemistry training program OR in a Royal College of Physicians and Surgeons of Canada-accredited medical biochemistry training program.
3. They are presenting work at the Annual Conference of the CSCC that they performed during their current traineeship.

In awarding the travel grants, the CSCC Awards Committee will consider the following additional criteria:

1. Preference will be given to trainees:

• In their final year of study,
• That have not previously received a CSCC Trainee Travel Grant,
• Presenting more than one abstract at the conference, AND
• Who reside outside of the city where the conference is being held.

2. Abstracts will be evaluated based on the amount of work involved in the study and the applicability of the results to the practice of Clinical/Medical Biochemistry. Preference will be given to clinical abstracts, followed by analytical abstracts, followed by basic research.
3. Whenever possible, grants will be distributed across two or more training programs. Eligible trainees must notify CSCC Head Office (office@cscc.ca) of their intention to apply after submission of their abstract(s) through the abstract submission system; notification must occur within 2 weeks of the abstract submission deadline.

Trainees must send ALL the following information to CSCC Head Office to be considered for this Grant:

1. Name and institution of their training program,
2. Current year of training,
3. A copy of their submitted abstract, AND
4. Proof of acceptance of the abstract for presentation (Submitted within two weeks of notification of acceptance of abstract(s) by the conference organizing committee). Applicants will be notified by Head Office as soon as possible after all complete travel grant applications have been reviewed.

Updated and approved by CSCC Council on April 12, 2017.

CSCC Grant for Educational Activities

1. The Grant(s) shall be presented to a Full member(s) of the CSCC to support their educational activities and/or development of the profession in the field of Clinical Chemistry or Pathology and Laboratory Medicine. The grant is intended to encourage and support Full CSCC members who require additional funding, beyond that provided by their employer, to attend national/international conferences or take additional courses, including (but not limited to): a. Attendance at the CSCC annual meeting or another national or international meeting relevant to Laboratory Medicine b. Visiting other laboratories to obtain specialized expertise in areas of Laboratory Medicine c. Attendance at provincial, national, or international Courses, Workshops, Task Forces or Committees that promote professional development in Laboratory Medicine.
2. This grant is not intended to cover examination fees or related expenses
3. Candidates will submit an application to the Awards Committee through the Head Office of the Society. The deadline for applications is November 30th each year. Candidates will submit with their application a statement explaining why this award is required, and a proposed budget. If their employer provides funds for education and travel, the candidates shall explain why these funds cannot be used for the purpose requested.
4. The grant shall usually be presented annually, but, if in the opinion of the Awards Committee, no suitable candidate is available, the Grant shall not be made. A maximum of three awards shall be given in any fiscal year. The deadline for application for the grant shall be November 30 of the previous year.
5. Recipients of the Grant shall receive a maximum of $3000, sponsored by the CSCC Council.  Awarding of this grant is subject to available funds from the CSCC.  Grant amounts may be reduced, or the grant may not be funded in any given year, at the discretion of the Council.
6. The Awards Committee shall choose the recipient(s) of the grant.
7. The Awards Committee shall report its choice(s) to the Council at the Winter Council meeting in the year for which the grant is made.
8. The President of the Society will notify recipient(s) not later than March 1 in the year in which the grant is made.
9. Grant recipients must provide a full accounting of expenses not more than sixty days following completion of the funded activity.
10. The recipient(s) is not usually required to give an address or paper, but the grants will be announced and the awardee(s) recognized at the Annual Meeting of the Society.
11. The amendment of the Terms of Reference is the responsibility of the Council., The terms of reference should be reviewed every five years.

CSCC Grant for Education Application Form

CSCC REGIONAL GRANT TOR

1. PROVINCIAL EDUCATION GRANTS Purpose

The purpose of Provincial Education Grants is to assist provincial societies with the provision of educational activities for their members. To further this goal, funding is allocated in advance to each provincial section so that they can plan events with the assurance that funds will be available. Funds will only be disbursed following the actual event. Amount of Grant: up to a maximum of $1,000 payable upon receipt of invoices

2. TRAVELLING LECTURESHIP

Purpose

Host cities are responsible for any hospitality extended to the Travelling Lecturer. Generally this consists of a dinner on one of the nights the lecturer is in town. The host city is also responsible for an additional honorarium for the lecturer, if he/she is asked to give additional talks after the initial one. CSCC covers all other costs including travel, accommodation, and honorarium.

Amount of Grant: up to a maximum of $1,000 payable upon receipt of invoices

PROCEDURE

1. Application for the grant is to be made to CSCC Head Office and the Head of the Education and Scientific Affairs Division (ESAD) with supporting documentation of the event in the form of copies of the program and a proposed budget.
2. Request for reimbursement must be received at CSCC Head Office by November 30 of the year in which the event occurred.
3. If a host does not have the ability to fund an event, application for an advance may be made to the Head ESAD. At the discretion of the Head and the Treasurer, funds can be advanced on the understanding that documentation of how the funds were used will be provided after the event takes place.

Approved June 2015

CSCC REGIONAL GRANT APPLICATION FORM

CSCC REGIONAL GRANT APPLICATION FORM TO HOST THE TRAVELLING LECTURESHIP